Yeast Expression System-Based Therapeutic Protein Production
Inquiry
The yeast expression system combines the advantages of prokaryotic and higher eukaryotic systems and is an important tool for the production of therapeutic proteins. As a trusted protein production contract organization, CD Formulation is committed to providing customers with high-quality protein production services. We have rich experience in host cell resources and vector selection, which can effectively increase cell density and protein production.
What is The Yeast Expression System?
The yeast expression system is one of the commonly used systems for eukaryotic protein expression. It has the advantages of a short prokaryotic expression cycle, low cost, and easy operation, and is easy to scale up for industrial-level culture. At the same time, it has the ability of eukaryotic cells to fold proteins spatially and modify glycosylation. The system clones the target gene into an appropriate expression vector and then transforms it into yeast cells, using its efficient transcription, translation, and subsequent modification capabilities to synthesize the target protein. Since the yeast expression system can be cultured on a large scale and is relatively low in cost compared to mammalian cells, it is suitable for large-scale protein production. Commonly used yeast species are Saccharomyces cerevisiae and Pichia pastoris. Saccharomyces cerevisiae has good genetic tools and mature genetic engineering technology, while Pichia pastoris is widely popular for its high-density fermentation ability and efficient protein expression.
Fig. 1 Schematic representation of engineered yeast secreting humanized therapeutic proteins. (Madhavan A, et al., 2021)
Explore Our Yeast Expression System-Based Therapeutic Protein Production Services
As a leading protein production contract organization, CD Formulation is focused on providing high-quality therapeutic protein production services to customers around the world. Our professional team has extensive experience in providing customized solutions for a wide range of biopharmaceutical products.
Our yeast expression system-based therapeutic protein production services cover all steps from DNA synthesis to vector construction to protein production. Our scientists optimize codons according to the codon preferences of different yeasts and improve protein production by considering gene dosage, integration site, transformant phenotype, and culture conditions.
Codon Optimization and Gene Synthesis (Optional)
Virus Generation
- The synthesized gene was cloned into a suitable expression vector.
- Plasmid sequencing and large-scale plasmid preparation.
Identification and Screening of High-Expression Strains
- PCR determined positive transformants.
- High-copy transformants were screened for target protein expression.
Protein Expression Analysis
Small-scale expression tests were performed on selected monoclonal strains.
Expression and Purification
- Small-scale expression, purification, and optimization of expression conditions.
- QC analysis: SDS-PAGE, UV, etc.
Large-scale Expression and Purification (Optional)
- A large-scale expression and purification according to the selected appropriate expression conditions.
- QC analysis: SDS-PAGE, UV, etc.
Target Protein Identification
- Identify the protein using qualitative or quantitative analysis methods.
- Purified proteins (can be lyophilized).
Available Yeast Expression Systems
Saccharomyces Cerevisiae |
Pichia Pastoris |
- The most classic yeast expression system.
- The complete genome sequence is known.
- Rapid growth, easy to culture and transform.
- Capable of simple post-transcriptional modifications (such as glycosylation).
- Suitable for the production of some proteins that require specific glycosylation modifications.
- Recognized as safe, and non-toxic.
- The ability to secrete proteins.
- Ability to undergo post-translationally modification.
|
- A yeast expression system that has gained popularity in recent years.
- Grow in high-density cultures with high protein yields.
- Powerful inducible promoter.
- Easy to operate.
- Good post-transcriptional modification capabilities, capable of producing complex glycosylation profiles.
- Suitable for expressing proteins that are difficult to obtain in other systems.
- Requirement for precise fermentation conditions.
- Capable of a variety of post-translational modifications.
|
Features of Yeast Expression System
- Rapid growth and relatively simple culture conditions make it suitable for large-scale fermentation production.
- Compared with other eukaryotic systems (such as mammalian cells), yeast culture and operation are relatively simple and low-cost.
- Complex post-translational modifications.
- Easy to precisely modify the yeast genome.
- Easy to purify and separate for subsequent proteins.
- Non-pathogenic microorganisms, high safety.
Our Different Expression Platforms for Therapeutic Protein Production
Expression Platform |
Properties |
|
Growth Speed |
Expression Level |
Production Time |
Contamination Risk |
Posttranslational Modification |
Protein Folding |
Phosphorylation |
Acetylation |
N-linked glycosulation |
O-linked glycosulation |
Acylation |
Yeast |
Rapid |
Low-High |
Medium |
Low |
Sometimes |
Yes |
Yes |
High Mannitol |
Yes |
Yes |
Baculovirus-Insect Cell |
Slow |
Low-High |
High |
High (e.g., virus) |
Suitable |
Yes |
Yes |
Simple |
Yes |
Yes |
E. coli |
Rapid |
High |
Low |
Medium (e.g., endotoxin) |
Need |
No |
No |
No |
No |
No |
Mammalian Cell |
Slow |
Low-Medium |
High |
Very high (e.g., virus, DNA) |
Suitable |
Yes |
Yes |
Complex |
Yes |
Yes |
Why Choose Us for Therapeutic Protein Production Using Yeast Expression System?
- Our team consists of experts with extensive experience in protein production, fermentation technology, and yeast biology.
- We have successfully developed and produced many therapeutic proteins using yeast systems.
- We excel in producing complex proteins that require specific glycosylation patterns using cutting-edge yeast expression systems such as Pichia pastoris and Saccharomyces cerevisiae.
- We use optimized expression and purification protocols to obtain high yields of therapeutic proteins with minimal impurities.
- We provide scalable therapeutic protein production solutions, from small-scale laboratory experiments to large-scale production for clinical trials and commercialization.
- Our optimized protocols reduce production time, speed up the development process, and bring your product to market faster.
Publication
Published Data
Technology: Cell Free Protein Synthesis Versus Yeast Expression
Journal: Protein Expr Purif.
IF: 1.4
Published: 2021
Results:
The authors investigated the PURE (Protein Synthesis Using Recombinant Elements) IVTT system based on recombinant proteins from E. coli. The expression and performance of human insulin (HI) analogs were evaluated using this system and compared to the Saccharomyces cerevisiae expression system. The results showed that the IVTT-expressed proteins have great potential for small-scale recombinant protein expression. The protein expression response was significantly improved by optimizing its redox potential using PUREFrex 2.1 and adding molecular chaperones to aid protein folding and solubility.
Fig. 2 IVTT Insulin precursor expression using PUREFrex. (Jensen AB, et al., 2021)
Thanks to our in-house advanced yeast expression platform, CD Formulation is committed to providing efficient and economical production of therapeutic proteins. Please don't hesitate to contact us if you are interested in our services. We look forward to cooperating with you.
References
- Madhavan A, Arun KB, Sindhu R, et al. Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up. Microb Cell Fact. 2021 Jun 30;20(1):124.
- Karbalaei M, Rezaee SA, Farsiani H. Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins. J Cell Physiol. 2020 Sep;235(9):5867-5881.
- Vieira Gomes AM, Souza Carmo T, Silva Carvalho L, et al. Comparison of Yeasts as Hosts for Recombinant Protein Production. Microorganisms. 2018 Apr 29;6(2):38.
- Jensen AB, Hubálek F, Stidsen CE, et al. Cell free protein synthesis versus yeast expression - A comparison using insulin as a model protein. Protein Expr Purif. 2021 Oct;186:105910.
How It Works
STEP 2
We'll email you to provide your quote and confirm order details if applicable.
STEP 3
Execute the project with real-time communication, and deliver the final report promptly.
Related Services